JMIR Publications

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 15.02.11 in Vol 13, No 1 (2011): Jan-Mar

This paper is in the following e-collection/theme issue:

Works citing "Packaging and Labeling of Pharmaceutical Products Obtained from the Internet"

According to Crossref, the following articles are citing this article (DOI 10.2196/jmir.1441):

(note that this is only a small subset of citations)

  1. Vanhee C, Janvier S, Desmedt B, Moens G, Deconinck E, De Beer JO, Courselle P. Analysis of illegal peptide biopharmaceuticals frequently encountered by controlling agencies. Talanta 2015;142:1
    CrossRef
  2. Vanhee C, Moens G, Van Hoeck E, Deconinck E, De Beer JO. Identification of the small research tetra peptide Epitalon, assumed to be a potential treatment for cancer, old age andRetinitis Pigmentosain two illegal pharmaceutical preparations. Drug Testing and Analysis 2015;7(3):259
    CrossRef
  3. Johnston A, Holt DW. Substandard drugs: a potential crisis for public health. British Journal of Clinical Pharmacology 2014;78(2):218
    CrossRef
  4. Pires CM, Cavaco AM. Exploring the perspectives of potential consumers and healthcare professionals on the readability of a package insert: a case study of an over-the-counter medicine. European Journal of Clinical Pharmacology 2014;70(5):583
    CrossRef
  5. Gelatti U, Pedrazzani R, Marcantoni C, Mascaretti S, Repice C, Filippucci L, Zerbini I, Dal Grande M, Orizio G, Feretti D. ‘You’ve got m@il: Fluoxetine coming soon!’: Accessibility and quality of a prescription drug sold on the web. International Journal of Drug Policy 2013;24(5):392
    CrossRef
  6. Cicero TJ, Ellis MS. Health Outcomes in Patients Using No-Prescription Online Pharmacies to Purchase Prescription Drugs. Journal of Medical Internet Research 2012;14(6):e174
    CrossRef